Nina Pinwill BSc (Hons) MSc DIC, is the Head of Commercial Operations, Commercial Medicines Directorate at NHS England, and a member of the EXCITE International Payers' Advisory Committee.
Nina Pinwill leads the commercial planning for Specialised Commissioning and the Cancer Drugs Fund (CDF) at NHS England. Nina’s role is to ensure that patients have faster access to the most promising new treatments, taxpayers get better value for money in drug expenditure and the route to funding is speeded up for responsibly priced, promising drugs. Nina’s role also includes responsibility for patient access schemes (PAS), the Blueteq prior approval system, dose banding and budget impact tests. Nina is London based.
Nina received her first degree in Geography in 1995 and spent the next five years in various management and planning roles in the Lord Chancellors Department (now the Ministry of Justice). Nina then spent the next 16 years working at the National Institute for Health and Care Excellence (NICE); the independent organisation responsible for providing national guidance on promoting good health and preventing and treating ill health in England. Nina has developed and improved various processes at NICE such as the process for technology appraisal and redesigning how NICE choose the topics it produces guidance on. Most recently at NICE Nina’s focus was on the set up, launch and subsequent operation of a new engagement function for the life sciences sector, called the Office for Market Access.
Nina also spent 2015 seconded to the Office for Life Sciences (a joint venture between Department of Health and Social Care and Department for Business, Energy & Industrial Strategy) as a Senior Policy Lead working on the Accelerated Access Review.
Nina gained her MSc in Health Policy from Imperial College London in May 2016 and is a trustee for the Waldenström's Macroglobulinemia UK charity.
BSc (Hons) MSc DIC, Head of Commercial Operations at NHS England